Virpax Pharmaceuticals Inc. (VRPX)
$0.00
$-0.22
(-99.91%)
As on 25-Aug-2026 16:00EDT
Market cap
$0 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-23.6 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-0
-
Debt to Equity
--
-
Book Value
$--
-
EPS
$-2.8
-
Face value
--
-
Shares outstanding
1,242,504
6 Years Aggregate
CFO
$-46.56 Mln
EBITDA
$-60.55 Mln
Net Profit
$-59.35 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Virpax Pharmaceuticals (VRPX)
| -- | -- | -- | -- | -99.0 | -96.5 | -- |
|
BSE Sensex*
| -8.5 | 1.9 | 1.3 | -5.1 | 6.1 | 6.7 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
|---|---|---|---|
|
Virpax Pharmaceuticals (VRPX)
| -87.9 | -48.6 | -81.9 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Virpax Pharmaceuticals (VRPX)
|
0.0 | 0.0 | 0.0 | -12.1 | -- | -2364.8 | -- | 0.5 |
| 89.1 | 12,304.7 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.4 | |
| 79.2 | 10,682.6 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 56.1 | 13,400.0 | 2,435.9 | 860.6 | 31.0 | 43 | 17 | 7.3 | |
| 107.1 | 12,277.1 | 1,663.7 | 413.6 | 36.3 | 430 | 31.2 | 83.9 | |
| 359.8 | 10,258.4 | 440.5 | 241.5 | 33.4 | 18.7 | 42.2 | 7.3 | |
| 538.9 | 11,938.8 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 22.9 | |
| 619.1 | 17,326.2 | 2,782.3 | 491.5 | 21.1 | 110.1 | 36.5 | 39.4 | |
| 377.4 | 10,496.2 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 | |
| 151.5 | 9,985.8 | 282.0 | 82.9 | -28.6 | 11.4 | 147 | 11.6 |
Shareholding Pattern
View DetailsAbout Virpax Pharmaceuticals (VRPX)
Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments for central nervous system... disorders. Its preclinical stage product candidates include Epoladerm, a topical spray film delivery technology for osteoarthritis pain; Probudur, an injectable local anesthetic liposomal gel technology for postoperative pain management; and Envelta, a nanotechnology-based intranasal spray drug product candidate that enables the delivery of a metabolically labile peptide drug into the brain. The company's preclinical stage product candidates also include AnQlar, an anti-viral barrier to prevent or reduce the risk or the intensity of viral infections in humans, including influenza and SARS-CoV-2; and NobrXiol, an investigational formulation to be delivered via the nasal route to enhance cannabidiol transport to the brain. Virpax Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Berwyn, Pennsylvania. Read more
-
CEO & Director
Mr. Gerald W. Bruce
-
CEO & Chairman
Mr. Gerald W. Bruce
-
Headquarters
Berwyn, PA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Virpax Pharmaceuticals (VRPX)
What is the current share price of Virpax Pharmaceuticals Inc (VRPX) Today?
The share price of Virpax Pharmaceuticals Inc (VRPX) is $0.00 (NASDAQ) as of 25-Aug-2026 16:00 EDT. Virpax Pharmaceuticals Inc (VRPX) has given a return of -99.03% in the last 3 years.
What is the current PB & PE ratio of Virpax Pharmaceuticals Inc (VRPX)?
Since, TTM earnings of Virpax Pharmaceuticals Inc (VRPX) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2024 |
-0.13 |
-1.77 |
2023 |
-0.02 |
0.19 |
2022 |
-0.03 |
0.04 |
2021 |
-1.89 |
0.61 |
2020 |
-- |
-- |
What is the 52 Week High and Low of Virpax Pharmaceuticals Inc (VRPX)?
The 52-week high and low of Virpax Pharmaceuticals Inc (VRPX) are Rs 0.02 and Rs 0.00 as of 27-Aug-2026.
What is the market cap of Virpax Pharmaceuticals Inc (VRPX)?
Virpax Pharmaceuticals Inc (VRPX) has a market capitalisation of $ 0 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Virpax Pharmaceuticals Inc (VRPX)?
Before investing in Virpax Pharmaceuticals Inc (VRPX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.